Rain Oncology lays off 65% of staff after PhIII trial failure

Rain Oncology will let go 65% of its workers, stop enrolling patients in a basket trial and nix plans for another study of its sole asset following a Phase III failure last week. The Newark, CA-based biotech had 63 full-time employees at the end of 2022, suggesting that several dozen…